A British American Tobacco (BAT) subsidiary is investing a further CAD124.6m (USD90.2m) in its strategic partnership with Canadian licensed cannabis producer Organigram.

The investment will be through 38.7m shares to be issued over three tranches. BAT will also increase its equity position from around 19% to 45%.


Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us